Price$25.83+0.03 (+0.12%)
01:30 PM07:45 PM
News · 26 weeks44+14%
2025-12-142026-06-07
Mix2690d
- Other16(62%)
- SEC Filings5(19%)
- Leadership2(8%)
- Dividends2(8%)
- Earnings1(4%)
Latest news
25 items- PRWellSpan Health and Philips Announce Landmark Strategic Alliance, Accelerating Innovation and Research Across Central Pennsylvania and Northern MarylandJune 4, 2026 Seven-year collaboration puts WellSpan at the forefront of diagnostics and imaging in community health through a groundbreaking research and innovation strategy aimed at shaping the future of care delivery Amsterdam and YORK, Pa. – Royal Philips (NYSE:PHG, AEX: PHIA)), a global leader in health technology, and WellSpan Health, the leading health care system in Central Pennsylvania and Northern Maryland, today announced a landmark seven-year strategic alliance that establishes a new research and innovation collaboration and brings new advanced imaging and diagnostics technology products and platforms to patients across the region. The alliance is the latest addition to WellSpan
- SECSEC Form 6-K filed by Koninklijke Philips N.V. NY Registry Shares6-K - KONINKLIJKE PHILIPS NV (0000313216) (Filer)
- PRPhilips Lumea IPL 9000 Series and Philips Sonicare 6400 Electric Toothbrush Selected as Good Housekeeping 2026 Beauty Awards WinnersTwo standout innovations recognized for excellence in body skincare and oral care Royal Philips (NYSE: PHG, AEX: PHIA) Two standout Philips innovations, Lumea IPL 9000 Series and Sonicare 6400, were named winners in Good Housekeeping's 2026 Beauty Awards. The full list of award winners can be found at goodhousekeeping.com/beautyawards2026. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260602515443/en/Philips Sonicare 64000 Electric Toothbrush From the global no. 1 IPL brand1, Lumea IPL 9000 Series was recognized in the ‘skin-boosting body care' category as the ‘DIY Laser Hair Removal' product. Lumea IPL harnesses the power of
- PRPhilips receives FDA 510(k) clearance for Elevate Plus for EPIQ Elite and Affiniti, delivering AI advancements in general imaging ultrasoundJune 2, 2026 Philips receives FDA 510(k) clearance for Elevate Plus for EPIQ Elite and Affiniti, delivering AI advancements in general imaging ultrasound AI-powered workflow automation helps clinicians acquire high-quality reproducible images faster and with greater confidence Amsterdam, the Netherlands – Royal Philips (NYSE:PHG, AEX: PHIA)), a global leader in health technology, today announced regulatory clearance in the USA of Elevate Plus, bringing advanced imaging and a suite of AI and automation capabilities to Philips EPIQ Elite and Affiniti, its flagship ultrasound systems. With CE Mark and 510(k) clearance, Elevate Plus helps standardize routine exams and reduce the need for re
- PRPhilips announces exchange ratio for 2025 dividendJune 2, 2026 Amsterdam, the Netherlands – Royal Philips (NYSE:PHG, AEX: PHIA)), today announced that the exchange ratio for the dividend for the year 2025 is 1 new common share for every 26.9341 existing common shares. This ratio was based on the volume-weighted average price of all traded common shares Koninklijke Philips N.V. at Euronext Amsterdam on May 27, 28 and 29, 2026, of EUR 22.8640 and was calculated in a manner that the gross dividend in shares will be approximately equal to EUR 0.85. As a result, Philips will issue a total number of 19,964,655 new common shares. Shareholders have been given the opportunity to make their choice between a dividend in shares or in cash. The aggreg
- PRPhilips highlights advances in imaging and physiology to support complex PCI at EuroPCR 2026May 18, 2026 From imaging to AI-enabled guidance, Philips connects technologies into a unified workflow to improve efficiency, reduce radiation exposure and support procedural confidenceAmsterdam, the Netherlands – As cardiac procedures become more complex, interventional cardiologists must balance the need for precise imaging and decision-making with growing pressure to reduce radiation exposure for both patients and staff. At EuroPCR 2026 in Paris (May 19–22), Royal Philips (NYSE:PHG, AEX: PHIA)), a global leader in health technology, will showcase how advances in imaging, physiology and real-time guidance can help clinicians manage complexity while supporting safer, lower-dose procedures
- PRPhilips introduces SmartIQ to address the trade-off between image quality and radiation dose in coronary proceduresMay 18, 2026 Greater differentiation of clinical details through contrast-rich images with reduced background noiseFor coronary procedures, a new ultra-low dose protocol employs over 50% less X-ray radiation dose [1]First SmartIQ clinical pilot study published in JSCAI, further building on Philips' strong track record in evidence generation [2] Amsterdam, the Netherlands – Royal Philips (NYSE:PHG, AEX: PHIA)), a global leader in health technology, today announced Philips SmartIQ, a breakthrough coronary imaging technology for its Azurion image-guided therapy. Developed in collaboration with leading cardiovascular centers, SmartIQ is designed to address one of the field's most fundam
- PRPhilips to deliver vital technology for hospital-at-home care for up to 15,000 patients annually in Region StockholmMay 18, 2026 Philips-led consortium selected through Karolinska University Hospital-led Region Stockholm tender to deliver advanced remote monitoring for complex patients Stockholm, Sweden - Royal Philips (NYSE:PHG, AEX: PHIA)), a global leader in health technology, today announced that a consortium composed of Philips, Cuviva and Vingmed has been selected to support Region Stockholm's hospital-at-home initiative, enabling hospital-level care to be delivered in patients' homes across the region. The consortium was selected through a tender led by Karolinska University Hospital for an advanced remote-monitoring program serving patients with complex or chronic conditions. The up to eight-ye
- SECSEC Form SD filed by Koninklijke Philips N.V. NY Registry SharesSD - KONINKLIJKE PHILIPS NV (0000313216) (Filer)
- SECSEC Form 6-K filed by Koninklijke Philips N.V. NY Registry Shares6-K - KONINKLIJKE PHILIPS NV (0000313216) (Filer)
- PRPhilips shareholders approve all proposals at the AGM 2026May 8, 2026 Amsterdam, the Netherlands – Royal Philips (NYSE:PHG, AEX: PHIA)), a global leader in health technology, today announced that its shareholders approved all proposals at the Annual General Meeting of Shareholders (AGM) 2026, including: Appointment of John DeFord (American, 1962) as new member of the Supervisory Board, with effect from May 8, 2026.Re-appointment of Paul Stoffels (Belgian, 1962), Herna Verhagen (Dutch, 1966) and Sanjay Poonen (American, 1969) as members of the Supervisory Board, with effect from May 8, 2026.Re-appointment of Roy Jakobs (Dutch/German, 1974) as President/CEO and Chairman and member of the Board of Management, with effect from May 8, 2026.Discharge o
- SECSEC Form 6-K filed by Koninklijke Philips N.V. NY Registry Shares6-K - KONINKLIJKE PHILIPS NV (0000313216) (Filer)
- PRPhilips delivers strong order intake, comparable sales growth and margin expansion in Q1; 2026 outlook reiteratedMay 6, 2026Q1 2026 Group performance Comparable order intake growth 6% Group sales of EUR 3.9 billion, reflecting 4% increase in comparable salesIncome from operations increased to EUR 241 millionAdjusted EBITA margin increased 40 basis points to 9.0%Operating cash flow of EUR 188 million, with free cash flow of EUR 28 million2026 outlook reiterated Roy Jakobs, CEO of Royal Philips:"We delivered a good start to 2026, with strong order intake growth at 6%, comparable sales growth of 4% and margin expansion of 40 basis points, reflecting disciplined execution against our plan in an uncertain macro-environment. Sales grew across segments and was led by North America and Europe. We are moving
- PRPhilips launches new Bridge Plus Occlusion Balloon to help manage rare but life-threatening SVC tears during lead extractionApril 23, 2026 Bridge Plus was designed for rare, life-threatening emergencies to help control bleeding during superior vena cava (SVC) tears, which occur in <0.5% of lead extraction procedures [1] but require immediate intervention Bridge Plus allows for rapid response when every second counts by deploying in under two minutes [2] and stopping up to 90% blood loss [3], helping stabilize patients with 30 minutes of hemostasis [4]Bridge Plus was built upon proven Bridge Occlusion Balloon technology, used in more than 50,000 U.S. procedures [5,*], with evidence showing improved survival when staged in advance [6,**] Amsterdam, the Netherlands – Royal Philips (NYSE:PHG, AEX: PHIA)), a globa
- PRPhilips receives FDA 510(k) clearance for its Rembra platform, expanding access to faster, more precise CT imaging across frontline care and cancer treatment planningApril 22, 2026 Clearances for Rembra CT, Rembra RT, and Areta RT enable high-throughput imaging at scale and elevate precision across the cancer care pathway Amsterdam, the Netherlands – Royal Philips (NYSE:PHG, AEX: PHIA)), a global leader in health technology, today announced it has received 510(k) clearance from the U.S. Food and Drug Administration (FDA) for its Rembra platform of scanning systems, including Rembra CT, Rembra RT and Areta RT. The newly cleared systems are designed to help healthcare providers respond to growing demand for imaging and radiation therapy planning by helping to improve speed, efficiency, and access to high-quality imaging. As imaging volumes and clinical
- PRPhilips receives FDA 510(k) clearance for Verida, the world's first AI-powered detector-based spectral CT*, advancing diagnostic precision across clinical applicationsApril 16, 2026 Combining always-on spectral imaging with AI reconstruction to deliver enhanced levels of image quality, efficiency, and clinical insight across radiology, cardiology, and oncology Amsterdam, the Netherlands – Royal Philips (NYSE:PHG, AEX: PHIA)), a global leader in health technology, today announced it has received U.S. Food and Drug Administration 510(k) clearance for the Philips Spectral CT Verida system, bringing its next-generation, AI-powered spectral CT innovation to the United States. AI-based reconstruction integrated into the imaging chain Verida incorporates Spectral Precise Image, with a third-generation Nano-panel Precise dual-layer detector with intrinsic noi
- SECSEC Form 6-K filed by Koninklijke Philips N.V. NY Registry Shares6-K - KONINKLIJKE PHILIPS NV (0000313216) (Filer)
- SECSEC Form 6-K filed by Koninklijke Philips N.V. NY Registry Shares6-K - KONINKLIJKE PHILIPS NV (0000313216) (Filer)
- PRFDA clears Philips AI solution that provides real-time guidance during complex minimally invasive heart valve repairMarch 26, 2026 Philips DeviceGuide uses AI to track and visualize mitral valve repair devices [1] in real time during minimally invasive procedures, supporting treatment [2]DeviceGuide integrates with Philips Azurion image-guided therapy platform that combines imaging, real-time data and intelligent software within a unified workflow to support more consistent, efficient and confidently guided minimally invasive procedures Amsterdam, the Netherlands – Royal Philips (NYSE:PHG, AEX: PHIA)), a global leader in health technology, today announced it has received U.S. Food and Drug Administration (FDA) 510(k) clearance for EchoNavigator R5.0 with DeviceGuide, an AI-powered software solution that
- PRPhilips launches IntraSight Plus to simplify coronary interventions and advance precision careMarch 25, 2026 Intuitive interventional cardiology platform combines the most comprehensive set of diagnostic and treatment planning tools to help support confident decisions and improved patient careWith FDA clearance and CE marking, IntraSight Plus streamlines the workflow efficiency of minimally invasive coronary procedures and can enable system operation time savings up to 47% in both the USA and Europe Amsterdam, the Netherlands – Royal Philips (NYSE:PHG, AEX: PHIA)), a global leader in health technology, has announced the launch of its intuitive interventional guidance platform, IntraSight Plus, which is cleared for clinical use in the USA and Europe. With CE marking and FDA 510(k) c
- PRPhilips remains No. 1 in Medtech at European Patent Office and the largest Dutch patent applicantMarch 24, 2026 Philips ranks No. 1 among medical technology companies in the European Patent Office Technology Dashboard 2025, filing 1,289 patent applications with the EPO in 2025.Philips' platform-based solutions integrate hardware, software, data and AI to address clinical, operational and everyday health challenges.Philips' innovation improved the lives of 2 billion people in 2025, with the goal of improving 2.5 billion lives per year by 2030, including 400 million people in medically underserved communities. Amsterdam, the Netherlands – Royal Philips (NYSE:PHG, AEX: PHIA)), a global leader in health technology, today announced it ranked No. 1 among medical technology companies in the
- PRPhilips convenes the Annual General Meeting of Shareholders 2026March 23, 2026 Amsterdam, the Netherlands – Royal Philips (NYSE:PHG, AEX: PHIA)), a global leader in health technology, today announced it has convened the Annual General Meeting of Shareholders (AGM) 2026 and published the agenda with explanatory notes. As previously announced, the agenda includes: Proposal to appoint John DeFord (American, 1962) as new member of the Supervisory Board, with effect from May 8, 2026.Proposals to re-appoint Paul Stoffels (Belgian, 1962), Herna Verhagen (Dutch, 1966) and Sanjay Poonen (American, 1969) as members of the Supervisory Board, with effect from May 8, 2026.Proposal to re-appoint Roy Jakobs (Dutch/German, 1974) as President/CEO and Chairman and memb
- PRPhilips proposes new appointment and re-appointments to its Supervisory Board and CEO re-appointmentMarch 23, 2026 John DeFord proposed as new member of the Supervisory Board.Paul Stoffels, Herna Verhagen and Sanjay Poonen proposed for re-appointment as members of the Supervisory Board.Marc Harrison will step down from Philips' Supervisory Board after his second term.Roy Jakobs proposed for re-appointment as President/CEO and Chairman and member of the Board of Management, as previously announced. Amsterdam, the Netherlands – Royal Philips (NYSE:PHG, AEX: PHIA)), a global leader in health technology, today announced a proposed Supervisory Board appointment and re-appointments, in addition to the previously announced proposal to re-appointment its President/CEO. The Supervisory Board wil
- PRPhilips Sonicare declares World Oral Health Night, spotlighting what manual brushing leaves behindMarch 20th, Philips Sonicare invites New Yorkers to rethink their nightly clean with an inside look at what happens in your mouth while you sleepCAMBRIDGE, Mass., March 17, 2026 /PRNewswire/ -- Royal Philips (NYSE: PHG, AEX: PHIA) and its Sonicare brand, the #1 Dental Professional recommended sonic toothbrush brand worldwide, is marking World Oral Health Day by declaring it World Oral Health Night drawing attention to a common risk to your oral health many people overlook: assuming manual brushing always removes enough plaque. The science shows why this moment before bed is so i
- PRPhilips expands digital pathology portfolio with cloud-enabled Philips IntelliSite Pathology Solution on HealthSuiteMarch 11, 2026 Fully cloud‑enabled solution designed to help healthcare organizations scale digital pathology adoption and workflows Amsterdam, The Netherlands – Royal Philips (NYSE:PHG, AEX: PHIA)), a global leader in health technology, today announced the expansion of its digital pathology portfolio with new cloud-enabled capabilities designed to help healthcare organizations scale digital diagnostics, improve productivity, and advance their transformation to fully digital workflows. Philips IntelliSite Pathology Solution on HealthSuite¹, powered by Amazon Web Services (AWS) is a fully cloud-enabled digital pathology solution that helps pathology laboratories adopt and scale digital wo
PHG FAQ
7 questionsWhat does Koninklijke Philips N.V. NY Registry Shares do?
Koninklijke Philips N.V. operates as a health technology company in North America, Greater China, and internationally. It operates through Diagnosis & Treatment, Connected Care, and Personal Health segments. It provides magnetic resonance imaging, computed tomography, advanced molecular imaging, diagnostic X-ray, and imaging components as well as integrated clinical solutions; integrated interventional systems, including interventional diagnostic and therapeutic devices; imaging products focused on diagnosis, treatment planning and guidance for cardiology, general imaging...Where does PHG stock trade?
Koninklijke Philips N.V. NY Registry Shares (PHG) is listed on NYSE.What sector and industry is PHG in?
Koninklijke Philips N.V. NY Registry Shares operates in the Health Care sector, Medical Electronics industry.Does PHG pay a dividend?
PHG's most recent ex-dividend date was 2026-05-13 with a cash dividend of $0.84 per share. No future ex-date is on file yet.What are analysts saying about PHG?
Koninklijke Philips N.V. NY Registry Shares has had 8 recent analyst actions on file. The most recent action was from RBC Capital Mkts: Sector Perform on 2025-12-17.What companies are similar to PHG?
Notable peers in the same industry include GEHC (GE HealthCare Technologies Inc.), HOLX (Hologic Inc.), BFLY (Butterfly Network Inc.), NNOX (NANO-X IMAGING LTD), CHEK (Check-Cap Ltd.). Compare PHG side-by-side with any of them on Quantisnow.How can I track PHG on Quantisnow?
Quantisnow aggregates Koninklijke Philips N.V. NY Registry Shares's SEC filings, analyst ratings, insider transactions, FDA approvals, and press releases the moment they hit the wire (Wall Street's wire, on your screen.). Follow PHG to receive live email and push alerts on every new disclosure.